trauma. Acute pain due to trauma
Conditions
Interventions
Intervention 1: Intervention group: Eating bromelain/serrapeptase capsules (250 mg bromelain and 30 mg serrapeptase per cap) BD (every 12 hours) for 10 days. Capsules are manufactured in "Dayan Teb Ek
Sponsors
Research and technology deputy, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Male and non-pregnant female age>18y Up to 1 week post trauma or surgery Wound size between 1-10 cm tend to use this supplement
Exclusion criteria
Exclusion criteria: Allergy to bromelain and serrapeptase Collagen Vascular or autoimmune Diseases mild-moderate and severe wound according to American infectious disease society criteria Using steroidal drugs in 2 months prior to study (exp. inhaled steroidal drugs for COPD and asthma and topical steroidal medication Using antibiotics in a week prior to study radiation therapy of wound HBA1c>10 venous insuf?ciency or osteomyelitis Using immunosuppressant active malignancies Renal disorders ((blood urea nitrogen < 21.4 mmol/l, creatinine < 247.5 umol/l) or liver failure MI in 3 months prior to study Drug or alcohol abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain of wound (trauma or surgical). Timepoint: Baseline and at the end of the study. Method of measurement: VAS (visual analog scale).;Size of wound (trauma or surgical). Timepoint: Baseline and at the end of the study. Method of measurement: Centimeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoodeh Razeghi Jahromi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed